Literature DB >> 11144549

Access to newer laboratory procedures: a call for action.

Y M Hale1, E P Desmond, K C Jost, M Salfinger.   

Abstract

Healthy People 2010, an initiative from the federal government, calls for action from tuberculosis controllers and tuberculosis laboratories in the fight to eliminate tuberculosis. Many patients, such as immunocompromised patients and those infected with multidrug-resistant tuberculosis strains, pose a challenge for care and diagnosis. Fortunately, many changes have occurred in the last decade to facilitate more rapid and accurate testing to assist with the care of these patients. California, Florida, New York and Texas have almost 50% of the tuberculosis cases in the United States, and their public health laboratories utilize different approaches to meet the same goal of rapid and accurate testing of specimens. With the targets of Healthy People 2010 (e.g., to reduce the average time for a laboratory to confirm and report tuberculosis cases to 2 days for 75% of cases) already looming on the horizon, innovative methods for achieving these goals should be evaluated. Using these public health laboratories as models, rapid, gold-standard testing methods should be provided to all patients in the United States. Soon it will be the year 2010..., are you ready to swiftly move forward?

Entities:  

Mesh:

Year:  2000        PMID: 11144549

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.

Authors:  Akos Somoskovi; Qunfeng Song; Judit Mester; Charise Tanner; Yvonne M Hale; Linda M Parsons; Max Salfinger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex?

Authors:  Akos Somoskovi; Anne Clobridge; Susan C Larsen; Oleg Sinyavskiy; Suheyla Surucuoglu; Linda M Parsons; Max Salfinger
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.

Authors:  Miguel Viveiros; Clara Leandro; Liliana Rodrigues; Josefina Almeida; Rosário Bettencourt; Isabel Couto; Lurdes Carrilho; José Diogo; Ana Fonseca; Luís Lito; João Lopes; Teresa Pacheco; Mariana Pessanha; Judite Quirim; Luísa Sancho; Max Salfinger; Leonard Amaral
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.

Authors:  Akos Somoskovi; Jillian Dormandy; Dimitra Mitsani; Jeremy Rivenburg; Max Salfinger
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

Review 5.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 6.  The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Authors:  A Somoskovi; L M Parsons; M Salfinger
Journal:  Respir Res       Date:  2001-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.